One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases

Digestion

Volumn 60, Issue 3, 1999, Pages 298-304

  Dajani, Asa'd I ^a,h   Awad, S ^b   Ukabam, S ^c   Nounou, M A ^d   Abdul Rasheed, Z ^e   Gautam, S ^e   Abdul Aal, G ^f   Nayal, S ^g  

^a Pan Arab Assoc of Gastroenterology   (United Arab Emirates)

^b Al Jazira Hospital   (United Arab Emirates)

^c TAWAM HOSPITAL   (United Arab Emirates)

^d Private Medical Centers   (United Arab Emirates)

^e Fujairah Hospital   (United Arab Emirates)

^f Al Baraha Hospital   (United Arab Emirates)

^g Emirates Medical Services   (United Arab Emirates)

^h Emirates Medical Association ^*  (United Arab Emirates)

Author keywords

Antibiotics; Eradication; Helicobacter pylori; Patient selection; Peptic ulcer disease; Proton pump inhibitors

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; MACROLIDE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; UREASE;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; DRUG EFFICACY; DUODENUM ULCER; ENDOSCOPY; ENZYME ASSAY; ETHNIC GROUP; FEMALE; FOLLOW UP; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH EROSION; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AMOXICILLIN; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BIOPSY; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; MALE; OMEPRAZOLE; SULFOXIDES; TREATMENT OUTCOME;

EID: 0032946946     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007675     Document Type: Article

References (51)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-1315.
2. Tytgat GNJ, Noach LA, Rauws EAJ: Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993;22: 127-139.
3. Decross A, Marshall B: The role of Helicobacter pylori in acid peptic disease. Am J Med Sci 1993;306:381-392.
4. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-69.
5. Veldhuyzen Van Zanten SJO: The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther 1997;11(suppl 1): 63-69.
6. Pounder RE, Williams MP: The treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11(suppl 1):35-41.
7. Forman D: The prevalence of Helicobacter pylori infection in gastric cancer. Aliment Pharmacol Ther 1995;9:71-76.
8. Uemura N, Mukai T, Okamoto S: Helicobacter pylori eradication inhibits the growth of intestinal type of gastric cancer in initial stage (abstract 282). Gastroenterology 1996;110, A282 (abstract).
9. Isaacson PG: Gastric lymphoma and Helicobacter pylori. N Engl J Med 1994;330:1310-1311.
10. Chiba N, Rao BV, Rademaker JW, Hunt RH: Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-1727.
11. Thijs JC, Van-Zweet AA, Oey HB: Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993;28:934-938.
12. De Boer WA, Tytgat GNJ: The best therapy for Helicobacter pylori infection: Should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995;30:401-407.
13. Adamek RJ, Szymanski C, Pfaffenbach B, et al: Kurzzeit Triple Therapie mit Pantoprazol, Clarithromycin und Metronidazol zur Heilung der Helicobacter pylori Infektion. Dtsch Med Wochenschr 1995;120:358-360.
14. Labenz J, Peitz U, Tillenburg B, et al: Short term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori. Leber Magen Darm 1995;25:122-127.
15. Lind T, Veldhuyzen Van Zanten SJO, Unge P: Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996;1:138-144.
16. Takimoto T, Satoh K, Taniguchi Y, Saifuku K, et al: The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients. Helicobacter 1997;2:86-91.
17. Stolzle L, Klann H, Topf G, et al: Ten day treatment with pantoprazole amoxicillin and metronidazole for cure of Helicobacter pylori infection. Gut 1997;112:A299.
18. Labenz J, Tillenburg B, Weismuller, et al: Efficacy and tolerability of a one week triple therapy consisting of pantoprazole, clarithromycin and amoxicillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. Aliment Pharmacol Ther 1997;11:95-100.
19. Jones DB, Howden CW, Burget DW, et al: Acid suppression in duodenal ulcer: A metaanalysis to define optimal dosing with antisecretory drugs. Gut 1987;28:1120-1127.
20. McIsaac RL, McCanless I, Summers K, et al: Ranitidine and cimetidine in the healing of duodenal ulcer: A meta-analysis of comparative clinical trials. Aliment Pharmacol Ther 1987;1:369-381.
21. Paulsen O, Hoglund P, Wakder M: No effect of omeprazole-induced hypoacidity on the bioavailability of amoxicillin or bacampicillin. Scand J Infect Dis 1989;21:219-223.
22. Rademaker JW, Zettel L, Jacobson K, Chiba N, Ernst PB, Hunt RH: Gastric juice immunoglobulins - Immunophysiological interaction in Helicobacter pylori infection. Gastroenterology 1993;104:A176.
23. Daw MA, Deegan P, Leen E, O'Morain C: The effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther 1991;5:435-439.
24. Megraud F, Bouchard S, Lamoulette M: Proton pump inhibitors have an antimicrobial activity against Helicobacter pylori. Gastroenterology 1991;100(suppl):123.
25. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T: Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: Unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993;37:769-744.
26. Kuhler T, Fryklund J, Bergman NA, Weilitz J, Larson H: Omeprazole and analogues inhibit urea dependent ammonia production by Helicobacter pylori. Acta Gastroenterol Belg 1993; 56:137.
27. Mauch F, Bode G, Malfertheiner P: Identification and characterisation of an ATPase system of Helicobacter pylori and effect of proton pump inhibitors. Am J Gastroenterol 1993;88: 1801-1802.
28. Dal NB, Di Mario F, Plebani M, Kusstatscher S, Vianello F, Basso D, et al: Early drop in anti-Helicobacter pylori IgG titre after eradication therapy with clarithromycin. Endoscopy 1995; 27 (issue 7).
29. Graham DY, Opekun AR, Klein PD: Clarithromycin for the eradication of Helicobacter pylori. J Clin Gastroenterol 1993;16:292-294.
30. Parasakthi N, Goh KL: Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia [letter] Am J Gastroenterol 1995;90:519.
31. Ghoneim AT, Langsdale P, Green R: Clarithromycin in duodenal ulcer treatment (abstract 347). Am J Gastroenterol 1994;89 (suppl):1372.
32. Tillenburg B, Labenz J, Siehoff S, et al: The situation of primary resistance of Helicobacter pylori to commonly used antibiotics in Germany (abstract P338). 60th Annu Sci Meet Am Coll Gastroenterol, 1995, New York. Am J Gastroenterol 1995;90:9.
33. Xia HX, Keane CT, O'Morain CA: A 5 year survey of metronidazole and clarithromycin resistance in clinical isolates of Helicobacter pylori (abstract 1A:09). Gut 1996;39(suppl 2):A6.
34. Megraud F, Cayla R, Lamouliatte H, et al: Surveillance of Helicobacter pylori resistance to macrolides and nitroimidazole compounds at a national level (abstract 334). Am J Gastroenterol 1994;89:1368.
35. Sung JJY, Chung SC, Ling TKW, Yung MY, Cheng AFB, Hosking SW, Li AKC: One year follow up of duodenal ulcers after one week triple therapy for Helicobacter pylori. Am J Gastroenterol 1994;89:199-202.
36. Labenz J, Borsch G : Highly significant change in the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-1788.
37. Wilhelmsen I, Weberg R, Berstad K, Hansken T, Hundal O, Berstad A: Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepatogastroenterology 1994;41:43-47.
38. Hosking SW, Ling TKW, Chung SC, Yung MY, Cheng FB: Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet 1994;343:508-510.
39. Labenz J, Ruhl GH, Bertrams J, Borsch G: Medium and high dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease. Dig Dis Sci 1994;39: 1483-1487.
40. Goh KL, Peh SC, Parasakthi N, Wong NW, Tan KK, Lo Y L: Omeprazole 40 mg o.m. combined with amoxicillin alone or with amoxicillin and metronidazole in the eradication of Helicobacter pylori. Am J Gastroenterol 1994; 89:1789-1792.
41. Labenz J, Ruhl GH, Bertrams J, Borsch G: Effective treatment after failure of omeprazole plus amoxicillin to eradicate Helicobacter pylori infection in peptic ulcer disease. Aliment Pharmacol Ther 1994;8:323-327.
42. Logan RPH, Gumett PA, Schaufelberger HD, Greaves RRFH, Mendelson GM, Walker MM, Thomas PH, Baron JH, Misiewicz JJ: Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994;35:323-326.
43. Neri M, Susi D, Laterza F, Diirio P, Seccia G, Mezzetti A, Cuccurullo F: Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1994;8:469-471.
44. Schwartz H, Krause R, Sahba B, Haber M, Weisfeld A, Rose P, Siepman N, Freston J: Triple versus dual therapy for eradicating H. pylori and preventing ulcer recurrence: A randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 1998;93:584-590.
45. Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, Jones PH, Brown C: Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-46.
46. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, Sottili S, Roda A, Roda E: Short term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-777.
47. Al Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY: Clarithromycin, tetracycline and bismuth: A new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994;89:1203-1205.
48. Al Assi MT, Genta RM, Karttunen TJ, Graham DY: Clarithromycin-amoxicillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1994;8:453-456.
49. Lamouliatte HC, Cayla R, Megraud F, et al: Amoxicillin-clarithromycin-omeprazole: The best therapy for Helicobacter pylori infection (abstract). Acta Gastroenterol Belg 1993;56 (suppl):140.
50. Moayyedi P, Tompkins DS, Axon ATR: Efficacy of ten days of clarithromycin, amoxicillin, and omeprazole in eradicating Helicobacter pylori infection (abstract 176). Gut 1995;37 (suppl 1):A44.
51. Goddard AF, Logan RP, Tonge KA, et al: Eradication of H. pylori infection using clarithromycin, omeprazole, and amoxicillin for one week (abstract). Gut 1995;37(suppl 1):A88.